Adulteration

FDA photo

Editor's Spotlight

FDA needs new tools in face of CBD explosion, official says

By Hank Schultz

FDA needs new tools to effectively deal with an expanding supplement marketplace, according to agency official Lowell Schiller. This is especially true when contemplating the flood of CBD products, with many more yet to come.

NutraIngredients-USA photo

BAPP’s adulterated materials SOP nearing final form

By Hank Schultz

The Botanical Adulterants Prevention Program is nearing the final stage of its initiative to offer industry a way to keep adulterated materials from turning up in finished goods on the shelf.

Getty Images

From the Editor's Desk

'Edgy' sports nutrition formulas cast a long and deep ethical shadow

By Hank Schultz

Temptation is a fact of human nature, and is an element in the sports nutrition game as well. Some sports products seem ever to edge toward an ethical line, spurred on by the demand from their consumer constituencies for ‘edgy’ formulations.

Getty Images

From the editor's desk

Imposition of tariffs puts spotlight on adulteration issue

By Hank Schultz

The fever pitch of the US-China trade war could turn up the heat on the adulteration issue within the dietary supplement industry. But one prominent expert says the issue must be viewed in a wider context.

Follow us

Featured Events

View more

Products

View more

Webinars